logo

Wave Life Sciences Ltd. (WVE)



Trade WVE now with
  Date
  Headline
12/30/2019 7:05:03 AM Wave Life Sciences Announces Topline Data And Addition Of Higher Dose Cohort In Phase 1b/2a PRECISION-HD2 Trial
12/16/2019 7:21:28 AM Wave Life Sciences To Discontinue Suvodirsen Development For DMD
9/5/2019 7:41:56 AM Wave Life Sciences Names Amy Pott, Heidi Wagner And Mark Corrigan To Board
1/24/2019 8:49:34 AM Wave Life Sciences Prices Public Offering Of 3.95 Mln Shares At $38.00/shr
12/6/2018 7:34:38 AM Wave Life Sciences Says Data From WVE-210201 Phase 1 Clinical Trial Support Initiation Of Phase 2/3 Trial
11/9/2018 7:43:21 AM Wave Life Sciences Q3 Net Loss $37.6 Mln
8/16/2018 8:04:34 AM Wave Life Sciences Gets US Orphan Drug And Rare Pediatric Disease Designations For WVE-210201
8/9/2018 8:21:37 AM Wave Life Sciences Q2 Net Loss Widens To $35.9 Mln From $24.6 Mln Last Year
7/2/2018 8:05:39 AM Wave Life Sciences Receives Positive Opinion For Orphan Drug Designation In EU For WVE-210201
5/9/2018 8:18:22 AM Wave Life Sciences Q1 Loss Per Share $1.26 Vs Loss $0.90 Last Year
3/12/2018 8:09:09 AM Wave Life Sciences Q4 Net Loss $30.2 Mln
11/14/2016 6:11:34 AM Jefferies Is Cutting Wave Life Sciences Ltd. (WVE) FY18 Estimate To -2.88 From -2.64
  
 
>